Literature DB >> 10416797

Transscleral choroidal biopsy in the diagnosis of choroidal lymphoma.

K Gündüz1, J A Shields, C L Shields, R C Eagle, W Diniz, G Mercado, W Chang.   

Abstract

A 57-year-old man with non-Hodgkin's B-cell lymphoma of the abdominal lymph nodes developed moderate cells in the anterior chamber and vitreous, choroidal infiltration, and total nonrhegmatogenous retinal detachment in both eyes while receiving chemotherapy. After a diagnostic vitrectomy in the left eye was nonrevealing, the patient was referred to the oncology service. Fine-needle aspiration biopsy of the choroidal infiltrate was not done because of poor visualization of the choroid through the turbid subretinal fluid. Transscleral choroidal biopsy was performed without complications and disclosed diffuse high-grade B-cell lymphoma and no signs of endogenous infection. Transscleral choroidal biopsy is a useful technique in eyes with choroidal infiltration, especially when hazy media prohibit fine needle biopsy.

Entities:  

Mesh:

Year:  1999        PMID: 10416797     DOI: 10.1016/s0039-6257(99)00041-7

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  3 in total

1.  The role of choroidal and retinal biopsies in the diagnosis and management of atypical presentations of uveitis.

Authors:  Lyndell L Lim; Eric B Suhler; James T Rosenbaum; David J Wilson
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 2.  Primary extranodal marginal zone B-cell lymphoma with diffuse uveal involvement and focal infiltration of the trabecular meshwork: a case report and review of literature.

Authors:  Xinxiao Gao; Bin Li; Qisheng You; Xiaoyan Peng
Journal:  BMC Ophthalmol       Date:  2015-05-07       Impact factor: 2.209

Review 3.  Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory Diseases.

Authors:  Rodolfo Mastropasqua; Emma Di Carlo; Carlo Sorrentino; Cesare Mariotti; Lyndon da Cruz
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.